Skip to Main Content

Paper Details

Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population.
J Card Fail
6
2022
CONCLUSIONS V122I TTR, NT-proBNP, Participants, TTR, TTR genotypes, V122I, V122I TTR, V122I TTR genotypes, V122I Transthyretin Variant, amino, amino terminal pro-B-type natriuretic peptide, amyloidosis, cardiovascular death, heart failure, participants, transthyretin

Datasets